{"id":1063,"date":"2026-06-28T13:28:43","date_gmt":"2026-06-28T13:28:43","guid":{"rendered":"https:\/\/gemaihealth.com\/?p=1063"},"modified":"2026-06-28T13:28:43","modified_gmt":"2026-06-28T13:28:43","slug":"mk-677-vs-ipamorelin","status":"publish","type":"post","link":"https:\/\/gemaihealth.com\/es\/mk-677-vs-ipamorelin\/","title":{"rendered":"MK-677 vs Ipamorelin: A Research Comparison"},"content":{"rendered":"<h2>Overview of MK-677 and Ipamorelin in Research<\/h2>\n<p>MK-677 (ibutamoren) and Ipamorelin are two widely studied research compounds that modulate growth hormone (GH) secretion through agonism of the ghrelin receptor. Both serve as valuable tools in laboratory investigations of endocrine regulation, muscle and bone physiology, and metabolic signaling pathways. MK-677 is a non-peptide, orally active small molecule, while Ipamorelin is a synthetic pentapeptide from the growth hormone\u2011releasing peptide (GHRP) family. Researchers compare these agents to understand differences in pharmacokinetics, receptor activation profiles, and experimental utility. All materials referenced here are strictly for laboratory research use only and are never intended for human or veterinary administration.<\/p>\n<ul>\n<li><strong>MK-677 (ibutamoren)<\/strong> \u2013 a spiroindoline\u2011based ghrelin receptor agonist with high oral bioavailability.<\/li>\n<li><strong>Ipamorelin<\/strong> \u2013 a peptide (Aib-His-D-2-Nal-D-Phe-Lys-NH\u2082) that potently and selectively triggers GH release.<\/li>\n<\/ul>\n<h2>Chemical Structure and Properties<\/h2>\n<h3>MK-677 (Ibutamoren)<\/h3>\n<p>MK-677 is a non-peptide small molecule with a molecular weight of approximately 337.4 g\/mol. Its chemical name is 2-amino-2-methyl-N-[(1R)-2-(1,1-dioxido-4-thiomorpholinyl)-1-[(phenylsulfonyl)methyl]ethyl]propanamide, and it possesses a chiral sulfonamide structure. The compound is lipophilic, which contributes to its excellent membrane permeability and oral bioavailability. In solution, MK-677 shows good stability under standard laboratory storage conditions (e.g., DMSO or ethanol stock solutions kept at \u201320\u00b0C). Its non-peptidic nature circumvents the enzymatic degradation that typically limits peptide-based agents, making it suitable for chronic oral administration protocols in animal models.<\/p>\n<h3>Ipamorelin<\/h3>\n<p>Ipamorelin is a fully synthetic pentapeptide with the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH\u2082. The N-terminus is capped with \u03b1-aminoisobutyric acid (Aib), which confers resistance to rapid peptidase cleavage. Its molecular weight is roughly 711.9 g\/mol. The presence of D\u2011amino acids (D\u20112\u2011naphthylalanine, D\u2011phenylalanine) and the C\u2011terminal amide further enhance metabolic stability relative to endogenous peptides, yet Ipamorelin remains susceptible to gastrointestinal degradation. Therefore, it is typically administered via parenteral routes (subcutaneous or intravenous injection) in research settings. Lyophilized Ipamorelin requires reconstitution in a suitable solvent and should be handled with aseptic technique to avoid degradation and contamination.<\/p>\n<h2>Mechanism of Action in Research<\/h2>\n<p>Both MK-677 and Ipamorelin exert their effects through the ghrelin receptor, also known as the growth hormone secretagogue receptor type 1a (GHS-R1a). This G\u2011protein\u2011coupled receptor is expressed in the anterior pituitary gland and hypothalamus, where its activation stimulates the release of growth hormone.<\/p>\n<ul>\n<li><strong>MK-677<\/strong> is a full agonist at GHS-R1a, mimicking the natural ligand ghrelin. It binds to the receptor with high affinity and produces a prolonged activation signal due to its non\u2011peptide structure and slower dissociation kinetics. This leads to sustained GH elevation in animal models.<\/li>\n<li><strong>Ipamorelin<\/strong> acts as a selective GHRP agonist. Although it binds to the same receptor, structural studies suggest a somewhat distinct binding pocket occupancy compared to MK-677. Ipamorelin\u2019s signaling profile is characterized by rapid receptor activation followed by swift clearance, resulting in a sharp, transient GH pulse.<\/li>\n<\/ul>\n<p>In primary pituitary cell cultures and rodent models, both compounds robustly increase GH secretion without altering the normal pulsatile pattern as severely as some earlier GHRPs. Researchers often use these agents to dissect ghrelin\u2011receptor\u2011mediated pathways, including the downstream activation of phospholipase C, inositol trisphosphate turnover, and intracellular calcium mobilization. Comparative studies note that MK\u2011677\u2019s prolonged receptor occupancy may lead to modest desensitization with continuous exposure, while Ipamorelin\u2019s short\u2011lived signal tends to preserve acute responsiveness in repeated\u2011dose experiments.<\/p>\n<h2>Research Applications<\/h2>\n<p>Because of their ability to reliably elevate endogenous GH, MK\u2011677 and Ipamorelin are employed across a spectrum of laboratory investigations:<\/p>\n<ul>\n<li><strong>Growth hormone axis studies<\/strong> \u2013 assessing feedback loops, IGF\u20111 induction, and pituitary sensitivity.<\/li>\n<li><strong>Muscle anabolism and atrophy models<\/strong> \u2013 explored in murine and rat studies examining protein synthesis and lean mass preservation during caloric restriction or disuse.<\/li>\n<li><strong>Bone density and turnover<\/strong> \u2013 investigated in ovariectomized rodent models for osteoporosis research.<\/li>\n<li><strong>Sleep and metabolic regulation<\/strong> \u2013 ghrelin receptor agonists influence sleep architecture and energy metabolism in animal paradigms.<\/li>\n<li><strong>Comparative PK\/PD profiling<\/strong> \u2013 direct head\u2011to\u2011head studies that quantify absorption, distribution, elimination, and effect duration.<\/li>\n<\/ul>\n<p>MK\u2011677\u2019s oral activity makes it especially suitable for chronic dosing experiments where repeated injection would be impractical or introduce handling stress. Ipamorelin, with its rapid onset and short half\u2011life, is frequently chosen for acute challenge tests that require precise timing of GH release, such as in pituitary function assays or pulsatile secretion modeling. Both compounds are also used as reference standards when developing and validating novel ghrelin mimetics.<\/p>\n<h2>Head-to-Head Comparison in Research Settings<\/h2>\n<p>When designing a study, investigators directly compare MK\u2011677 and Ipamorelin on several critical parameters. The table below (represented here as an unordered list) summarizes the key contrasts supported by published experimental data.<\/p>\n<ul>\n<li><strong>Half\u2011life in vivo<\/strong> \u2013 MK\u2011677 exhibits an extended plasma half\u2011life of approximately 4\u20136 hours in rodent and canine models, owing to its metabolic stability and high protein binding. Ipamorelin\u2019s half\u2011life is reported at roughly 30 minutes, consistent with rapid renal clearance and enzymatic breakdown.<\/li>\n<li><strong>Administration route<\/strong> \u2013 Oral gavage for MK\u2011677 (reliable bioavailability &gt;60 % in dogs, variable in rodents but consistent); subcutaneous or intravenous injection for Ipamorelin, which is essentially inactive orally.<\/li>\n<li><strong>Stability in solution<\/strong> \u2013 MK-677 remains stable in common organic solvents for extended periods. Ipamorelin, as a lyophilized peptide, is stable at \u201320\u00b0C, but once reconstituted in aqueous buffers, it has a limited working life (typically days to a week when refrigerated) due to aggregation and hydrolysis.<\/li>\n<li><strong>Potency (EC\u2085\u2080) at GHS-R1a<\/strong> \u2013 Both are potent, with reported EC\u2085\u2080 values in the low nanomolar range (typically 1\u201310 nM in cellular calcium flux or cAMP assays). Exact values vary with assay conditions and cell line. Some data suggest MK\u2011677 is slightly more potent in certain setups, while Ipamorelin\u2019s cleaner selectivity profile may yield a sharper signal in GH\u2011release assays.<\/li>\n<li><strong>Selectivity<\/strong> \u2013 Both are selective for the ghrelin receptor over other GPCRs; however, MK\u2011677 has shown minor off\u2011target activity at high concentrations in broad\u2011panel screens, whereas Ipamorelin\u2019s peptidic nature confers a narrower interaction profile.<\/li>\n<li><strong>Duration of GH elevation<\/strong> \u2013 MK\u2011677 induces a sustained, plateau\u2011like GH rise lasting several hours. Ipamorelin produces a rapid, high\u2011amplitude pulse that returns to baseline within roughly 2 hours.<\/li>\n<\/ul>\n<h2>Selecting the Right Peptide for Your Study<\/h2>\n<p>The choice between MK\u2011677 and Ipamorelin hinges on the experimental question, practical logistics, and the desired pharmacokinetic profile.<\/p>\n<ul>\n<li><strong>Oral vs. injectable protocol<\/strong> \u2013 If the model requires long\u2011term dosing without repeated handling stress, MK\u2011677 is the more practical option. For precise control over the timing of GH spikes (e.g., in pulsatility studies), Ipamorelin\u2019s injectable nature and short action are advantageous.<\/li>\n<li><strong>Duration of effect<\/strong> \u2013 Chronic elevation of GH\/IGF\u20111 often calls for MK\u2011677, while Ipamorelin is better suited when a transient, physiologically patterned pulse is needed.<\/li>\n<li><strong>Cost and availability<\/strong> \u2013 MK\u2011677 can be synthesized at scale and is generally more economical for large\u2011sample, long\u2011duration projects. Ipamorelin, being a specialty peptide with non\u2011natural amino acids, may carry a higher cost per milligram, which can be a factor in extensive dose\u2011response studies.<\/li>\n<li><strong>Purity and quality control<\/strong> \u2013 Whether sourcing from a peptide manufacturer or a chemical supplier, researchers should insist on independent HPLC and MS analysis, certificate of analysis, and stability data. The same rigor applies to both compounds; contaminated or degraded product can introduce significant variability.<\/li>\n<li><strong>Regulatory and ethical considerations<\/strong> \u2013 Both compounds are designated for research use only. Investigators must ensure that protocols are approved by their institutional animal care and use committee and that handling complies with all local regulations.<\/li>\n<\/ul>\n<h2>Summary of Key Differences<\/h2>\n<p><strong>MK-677 vs Ipamorelin<\/strong> represents a classic contrast between a non-peptide, orally active ghrelin mimetic and a peptide GHRP. MK\u2011677 offers the convenience of oral dosing, a long half\u2011life, and sustained GH secretion, making it a staple in chronic preclinical studies. Ipamorelin provides a rapid, self\u2011limiting GH pulse via injection, which is valuable for acute experimental designs and avoids the receptor desensitization occasionally observed with prolonged continuous agonism. Both remain indispensable in the researcher\u2019s toolkit for dissecting growth hormone biology, but the optimal selection depends entirely on the study\u2019s specific objectives, route of administration, and required temporal dynamics. By carefully aligning these factors with the established pharmacological properties of each compound, investigators can achieve robust, reproducible results in their laboratory investigations.<\/p>\n<p><strong>Research use only note<\/strong>: All products and compounds discussed here are strictly for laboratory research purposes. They are not intended for human or veterinary use, nor for diagnostic, therapeutic, or prophylactic applications. Any use outside of controlled laboratory settings is not authorized.<\/p>\n<p class=\"gse-disclaimer\"><em>For research use only. Not for human or veterinary use.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Overview of MK-677 and Ipamorelin in Research MK-677 (ibutamoren) and Ipamorelin are two widely studied research compounds that modulate growth hormone (GH) secretion through agonism of the ghrelin receptor. Both serve as valuable tools in laboratory investigations of endocrine regulation, muscle and bone physiology, and metabolic signaling pathways. MK-677 is a non-peptide, orally active small [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1064,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"news_category":[],"class_list":["post-1063","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MK-677 vs Ipamorelin: Research Comparison<\/title>\n<meta name=\"description\" content=\"Explore differences between MK-677 and Ipamorelin for research. Compare mechanisms, stability, and applications in lab studies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gemaihealth.com\/es\/mk-677-vs-ipamorelin\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MK-677 vs Ipamorelin: A Research Comparison\" \/>\n<meta property=\"og:description\" content=\"Explore differences between MK-677 and Ipamorelin for research. Compare mechanisms, stability, and applications in lab studies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gemaihealth.com\/es\/mk-677-vs-ipamorelin\/\" \/>\n<meta property=\"og:site_name\" content=\"Genmai Health\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-28T13:28:43+00:00\" \/>\n<meta name=\"author\" content=\"Genmai Health\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Genmai Health\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/\"},\"author\":{\"name\":\"Genmai Health\",\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/#\\\/schema\\\/person\\\/dccf4f0c78ff32fe7a4710d1d26bcc6f\"},\"headline\":\"MK-677 vs Ipamorelin: A Research Comparison\",\"datePublished\":\"2026-06-28T13:28:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/\"},\"wordCount\":1416,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/gemaihealth.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gse-cover-1063-5eTrnn.svg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/\",\"url\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/\",\"name\":\"MK-677 vs Ipamorelin: Research Comparison\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/gemaihealth.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gse-cover-1063-5eTrnn.svg\",\"datePublished\":\"2026-06-28T13:28:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/#\\\/schema\\\/person\\\/dccf4f0c78ff32fe7a4710d1d26bcc6f\"},\"description\":\"Explore differences between MK-677 and Ipamorelin for research. Compare mechanisms, stability, and applications in lab studies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/#primaryimage\",\"url\":\"https:\\\/\\\/gemaihealth.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gse-cover-1063-5eTrnn.svg\",\"contentUrl\":\"https:\\\/\\\/gemaihealth.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/gse-cover-1063-5eTrnn.svg\",\"caption\":\"MK-677 vs Ipamorelin\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/mk-677-vs-ipamorelin\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\\\/\\\/gemaihealth.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MK-677 vs Ipamorelin: A Research Comparison\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/#website\",\"url\":\"https:\\\/\\\/gemaihealth.com\\\/\",\"name\":\"Genmai Health\",\"description\":\"Research Peptides &amp; Exosomes Supplier\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/gemaihealth.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/gemaihealth.com\\\/#\\\/schema\\\/person\\\/dccf4f0c78ff32fe7a4710d1d26bcc6f\",\"name\":\"Genmai Health\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"Genmai Health\"},\"sameAs\":[\"https:\\\/\\\/gemaihealth.com\"],\"url\":\"https:\\\/\\\/gemaihealth.com\\\/es\\\/author\\\/jingrunacrylicgmail-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MK-677 vs Ipamorelin: Research Comparison","description":"Explore differences between MK-677 and Ipamorelin for research. Compare mechanisms, stability, and applications in lab studies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gemaihealth.com\/es\/mk-677-vs-ipamorelin\/","og_locale":"es_ES","og_type":"article","og_title":"MK-677 vs Ipamorelin: A Research Comparison","og_description":"Explore differences between MK-677 and Ipamorelin for research. Compare mechanisms, stability, and applications in lab studies.","og_url":"https:\/\/gemaihealth.com\/es\/mk-677-vs-ipamorelin\/","og_site_name":"Genmai Health","article_published_time":"2026-06-28T13:28:43+00:00","author":"Genmai Health","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Genmai Health","Tiempo de lectura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/#article","isPartOf":{"@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/"},"author":{"name":"Genmai Health","@id":"https:\/\/gemaihealth.com\/#\/schema\/person\/dccf4f0c78ff32fe7a4710d1d26bcc6f"},"headline":"MK-677 vs Ipamorelin: A Research Comparison","datePublished":"2026-06-28T13:28:43+00:00","mainEntityOfPage":{"@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/"},"wordCount":1416,"commentCount":0,"image":{"@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/#primaryimage"},"thumbnailUrl":"https:\/\/gemaihealth.com\/wp-content\/uploads\/2026\/06\/gse-cover-1063-5eTrnn.svg","articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/","url":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/","name":"MK-677 vs Ipamorelin: Research Comparison","isPartOf":{"@id":"https:\/\/gemaihealth.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/#primaryimage"},"image":{"@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/#primaryimage"},"thumbnailUrl":"https:\/\/gemaihealth.com\/wp-content\/uploads\/2026\/06\/gse-cover-1063-5eTrnn.svg","datePublished":"2026-06-28T13:28:43+00:00","author":{"@id":"https:\/\/gemaihealth.com\/#\/schema\/person\/dccf4f0c78ff32fe7a4710d1d26bcc6f"},"description":"Explore differences between MK-677 and Ipamorelin for research. Compare mechanisms, stability, and applications in lab studies.","breadcrumb":{"@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/#primaryimage","url":"https:\/\/gemaihealth.com\/wp-content\/uploads\/2026\/06\/gse-cover-1063-5eTrnn.svg","contentUrl":"https:\/\/gemaihealth.com\/wp-content\/uploads\/2026\/06\/gse-cover-1063-5eTrnn.svg","caption":"MK-677 vs Ipamorelin"},{"@type":"BreadcrumbList","@id":"https:\/\/gemaihealth.com\/mk-677-vs-ipamorelin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/gemaihealth.com\/"},{"@type":"ListItem","position":2,"name":"MK-677 vs Ipamorelin: A Research Comparison"}]},{"@type":"WebSite","@id":"https:\/\/gemaihealth.com\/#website","url":"https:\/\/gemaihealth.com\/","name":"Salud Genmai","description":"P\u00e9ptidos de investigaci\u00f3n y exosomas Proveedor","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gemaihealth.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/gemaihealth.com\/#\/schema\/person\/dccf4f0c78ff32fe7a4710d1d26bcc6f","name":"Salud Genmai","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"Genmai Health"},"sameAs":["https:\/\/gemaihealth.com"],"url":"https:\/\/gemaihealth.com\/es\/author\/jingrunacrylicgmail-com\/"}]}},"_links":{"self":[{"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/posts\/1063","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/comments?post=1063"}],"version-history":[{"count":1,"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/posts\/1063\/revisions"}],"predecessor-version":[{"id":1065,"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/posts\/1063\/revisions\/1065"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/media\/1064"}],"wp:attachment":[{"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/media?parent=1063"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/categories?post=1063"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/tags?post=1063"},{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/gemaihealth.com\/es\/wp-json\/wp\/v2\/news_category?post=1063"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}